These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16697606)

  • 21. Pediatric psychopharmacological research in the post EU regulation 1901/2006 era.
    Schmäl C; Becker K; Berg R; Brünger M; Lehmkuhl G; Oehler KU; Ruppert T; Staudter C; Trott GE; Dittmann RW
    Z Kinder Jugendpsychiatr Psychother; 2014 Nov; 42(6):441-9. PubMed ID: 25335522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased commercial financing of national Medical Product Agencies within the EU].
    Ramel B
    Lakartidningen; 2003 Jan; 100(5):338-9. PubMed ID: 12607381
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fundamental principles of clinical trials].
    Skarke C; Geisslinger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):401-7. PubMed ID: 15830250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical research on humans: regulation in Switzerland, the European Union, and the United States.
    Schott M
    Food Drug Law J; 2005; 60(1):45-77. PubMed ID: 15940854
    [No Abstract]   [Full Text] [Related]  

  • 26. Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary.
    Pandolfini C; Bonati M
    Arch Dis Child; 2008 Aug; 93(8):715. PubMed ID: 18644943
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the pharmaceutical industry in disseminating pharmacovigilance practice in developing countries.
    Shani S; Yahalom Z
    Food Drug Law J; 2008; 63(3):701-11. PubMed ID: 19031669
    [No Abstract]   [Full Text] [Related]  

  • 28. Deficiencies in proposed new EU regulation of clinical trials.
    Gøtzsche PC
    BMJ; 2012 Dec; 345():e8522. PubMed ID: 23258926
    [No Abstract]   [Full Text] [Related]  

  • 29. [European drug agency and drug management].
    Barfuss W
    Leber Magen Darm; 1996 Jul; 26(4):191-2. PubMed ID: 8965600
    [No Abstract]   [Full Text] [Related]  

  • 30. Future developments of clinical research in pediatrics: the role of the Journal Klinische Pädiatrie.
    Körholz D; Gortner L; Göbel U
    Klin Padiatr; 2013 Jul; 225(4):191-2. PubMed ID: 23904155
    [No Abstract]   [Full Text] [Related]  

  • 31. The need for proportionate regulation of clinical trials.
    Kearns P
    Lancet Oncol; 2013 May; 14(6):454-5. PubMed ID: 23522923
    [No Abstract]   [Full Text] [Related]  

  • 32. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 33. [The Medical Product Agency's work and economics--a comment].
    Ahlqvist Rastad J; Salmonson T
    Lakartidningen; 2003 Jan; 100(5):345. PubMed ID: 12607382
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].
    Johannesson M; Berglund EG
    Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388
    [No Abstract]   [Full Text] [Related]  

  • 35. "Recommendations concerning regulatory and legal aspects" contribution to the European task force on disease modifying trials in Alzheimer's disease.
    Rapp L
    J Nutr Health Aging; 2006; 10(2):139-41. PubMed ID: 16554950
    [No Abstract]   [Full Text] [Related]  

  • 36. Off label prescribing in children. Children's human rights are violated.
    Isitt VL
    BMJ; 2002 Aug; 325(7359):338. PubMed ID: 12173620
    [No Abstract]   [Full Text] [Related]  

  • 37. [Change of law concerning drug trials is needed: Sweden should allow testing in unconscious patients].
    Fagrell B; Riddez L
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3217-8. PubMed ID: 20101831
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modification of the prescribing practice of the physician by drug approval decisions of federal agencies].
    Wartensleben H
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):604-6. PubMed ID: 9527450
    [No Abstract]   [Full Text] [Related]  

  • 39. Better medicines for children--where are we now, and where do we want to be?
    Rose K
    Br J Clin Pharmacol; 2005 Jun; 59(6):657-9. PubMed ID: 15948927
    [No Abstract]   [Full Text] [Related]  

  • 40. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
    Altavilla A; Giaquinto C; Ceci A
    J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.